Aromatase Enzyme Activity and Liver Receptor Homolog-1 Levels in
Gestational Diabetes Mellitus

Nihayet      Bayraktar; Hasip      Tas; Mehmet      Bayraktar; Ismail      Koyuncu; İsmail      Sarı; Hacer      Uyanıkoğlu

doi:10.2174/1573408019666221103145729

Abstract

Background: Gestational diabetes mellitus (GDM) is one of the prediabetes conditions in which high blood sugar levels and body weight increase during pregnancy. The underlying molecular and biochemical mechanisms of GDM have been poorly defined.

Introduction: Aromatase enzyme activity is responsible for the conversion of androgens to estrogens and has a share in the regulation of body fat distribution and liver receptor homolog-1 (LRH- 1), which plays a critical role in cholesterol transport, acid homeostasis, and steroidogenesis in GDM patients. This study aims to determine the levels of aromatase enzyme and LRH-1 in GDM patients and to investigate the relationship between the levels of aromatase enzyme and LRH-1 and the levels of insulin, HbA 1c and total cholesterol.

Methods: This prospective cross-sectional study was conducted over eleven months (September 2020 to July 2021). The study population was selected at Harran University Teaching and Research Hospital. The study included 32 GDM patients and 32 healthy pregnants. The automated assay measured serum fasting blood glucose, HbA1c, and insulin levels (AVIDA 1800 Chemistry System; Siemens). Aromatase enzyme activity and LRH-1 levels were determined by using a commercial enzyme-linked immunosorbent assay (ELISA) kit.

Results: Aromatase activity decreased in GDM patients while LRH1 increased. Significant differences in means levels of fasting blood glucose (p = 0.11), insulin (p = 0.001) and HbA1c (p = 0.001) between the patients and control groups. There was a significant negative correlation between the levels of aromatase and insulin (r = -370, p = 0.037). In addition, a positive significant correlation coefficient (r = 0.645, p = 0.001) was found between HbA1c and total cholesterol among the patients' group.

Conclusion: Our findings indicate that there is a negative relationship between aromatase activity and insulin levels. Aromatase and LRH 1 may play a role in the pathogenesis of GDM, and the use of LRH-1 agonists in treating the disease may be considered an alternative treatment in the future. However, additional studies are required to reveal the possible functions of these two proteins in GDM with their mechanisms.

Keywords: Aromatase, liver receptor homolog-1, insulin, HbA1c, gestation, diabetes mellitus.

« Previous Next »

Graphical Abstract

[1]
Hevener AL, Clegg DJ, Mauvais-Jarvis F. Impaired estrogen receptor action in the pathogenesis of the metabolic syndrome. Mol Cell Endocrinol  2015; 418(Pt 3): 306-21.
 [http://dx.doi.org/10.1016/j.mce.2015.05.020] [PMID: 26033249]

[2]
Kampmann U, Madsen LR, Skajaa GO, Iversen DS, Moeller N, Ovesen P. Gestational diabetes: A clinical update. World J Diabetes  2015; 6(8): 1065-72.
 [http://dx.doi.org/10.4239/wjd.v6.i8.1065] [PMID: 26240703]

[3]
Satman I, Omer B, Tutuncu Y, et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol  2013; 28(2): 169-80.
 [http://dx.doi.org/10.1007/s10654-013-9771-5] [PMID: 23407904]

[4]
Kim C. Maternal outcomes and follow-up after gestational diabetes mellitus. Diabet Med  2014; 31(3): 292-301.
 [http://dx.doi.org/10.1111/dme.12382] [PMID: 24341443]

[5]
Moon JH, Kwak SH, Jang HC. Prevention of type 2 diabetes mellitus in women with previous gestational diabetes mellitus. Korean J Intern Med  2017; 32(1): 26-41.
 [http://dx.doi.org/10.3904/kjim.2016.203] [PMID: 28049284]

[6]
Gingrich J, Ticiani E, Veiga-Lopez A. Placenta disrupted: endocrine disrupting chemicals and pregnancy. Trends Endocrinol Metab  2020; 31(7): 508-24.
 [http://dx.doi.org/10.1016/j.tem.2020.03.003]

[7]
Li J, Leng J, Li W, et al. Roles of insulin resistance and beta cell dysfunction in macrosomia among Chinese women with gestational diabetes mellitus. Prim Care Diabetes  2018; 12(6): 565-73.
 [http://dx.doi.org/10.1016/j.pcd.2018.07.010] [PMID: 30115525]

[8]
Atta M, Almadaly E, El-Far A, et al. Thymoquinone defeats diabetes-induced testicular damage in rats targeting antioxidant, inflammatory and aromatase expression. Int J Mol Sci  2017; 18(5): 919.
 [http://dx.doi.org/10.3390/ijms18050919] [PMID: 28448463]

[9]
Hobeika E, Armouti M, Kala H, et al. Oocyte-secreted factors synergize with fsh to promote aromatase expression in primary human cumulus cells. J Clin Endocrinol Metab  2019; 104(5): 1667-76.
 [http://dx.doi.org/10.1210/jc.2018-01705] [PMID: 30541132]

[10]
Brown KA, Iyengar NM, Zhou XK, et al. Menopause Is a determinant of breast aromatase expression and its associations with BMI, inflammation, and systemic markers. J Clin Endocrinol Metab  2017; 102(5): 1692-701.
 [http://dx.doi.org/10.1210/jc.2016-3606] [PMID: 28323914]

[11]
Farrar D, Duley L, Dowswell T, Lawlor DA. Different strategies for diagnosing gestational diabetes to improve maternal and infant health. Cochrane Libr  2017; 2017(8): CD007122.
 [http://dx.doi.org/10.1002/14651858.CD007122.pub4] [PMID: 28832911]

[12]
Lowe WL, Scholtens DM, Lower LP, et al. Follow-up study cooperative research group. association of gestational diabetes with maternal disorders of glucose metabolism and childhood adiposity. JAMA  2018; 320(10): 1005-16.
 [http://dx.doi.org/10.1001/jama.2018.11628]

[13]
Jin J, Jin J, Woodfield S, et al. Targeting LRH 1 in hepatoblastoma cell lines causes decreased proliferation. Oncol Rep  2018; 41(1): 143-53.
 [http://dx.doi.org/10.3892/or.2018.6793] [PMID: 30320362]

[14]
Luo Z, Li Y, Zuo M, et al. Effect of NR5A2 inhibition on pancreatic cancer stem cell (CSC) properties and Epithelial-Mesenchymal Transition (EMT) markers. Mol Carcinog  2017; 56(5): 1438-48.
 [http://dx.doi.org/10.1002/mc.22604] [PMID: 27996162]

[15]
Colleluori G, Chen R, Turin CG, et al. aromatase inhibitors plus weight loss improves the hormonal profile of obese hypogonadal men without causing major side effects. Front Endocrinol  2020; 11: 277.
 [http://dx.doi.org/10.3389/fendo.2020.00277] [PMID: 32499757]

[16]
Zhang D, Cheng D, Liu T, Zhang Y, Chen ZJ, Zhang C. Dysfunction of liver receptor homolog-1 in decidua: possible relevance to the pathogenesis of preeclampsia. PLoS One  2015; 10(12): e0145968.
 [http://dx.doi.org/10.1371/journal.pone.0145968] [PMID: 26717016]

[17]
Stein SL, Vera-Xu P, Demagny H, et al. Impaired SUMOylation of nuclear receptor LRH-1 promotes nonalcoholic fatty liver disease. J Clin Invest  2017; 1127(2): 583-92.
 [http://dx.doi.org/10.1172/JCI85499]

[18]
Lin Q, Aihara A, Chung W, et al. LRH1 as a driving factor in pancreatic cancer growth. Cancer Lett  2014; 345(1): 85-90.
 [http://dx.doi.org/10.1016/j.canlet.2013.11.014] [PMID: 24333731]

[19]
Mrosek N, Meissburger B, Mataki C, et al. Transcriptional regulation of adipocyte formation bythe liver receptor homologue 1 (Lrh1)-Small hetero-dimerization partner (Shp) network. Mol Metab  2013; 2(3): 314-23.
 [http://dx.doi.org/10.1016/j.molmet.2013.03.003] [PMID: 24049743]

[20]
Prabhu A, Xu Q, Manigrasso MB, et al. Expression of aromatase, androgen and estrogen receptors in peripheral target tissues in diabetes. Steroids  2010; 75(11): 779-87.
 [http://dx.doi.org/10.1016/j.steroids.2009.12.012] [PMID: 20064538]

[21]
Olmos-Ortiz A, Flores-Espinosa P, Díaz L, Velázquez P, Ramírez-Isarraraz C, Zaga-Clavellina V. Immunoendocrine dysregulation during gestational diabetes mellitus: The central role of the placenta. Int J Mol Sci  2021; 22(15): 8087.
 [http://dx.doi.org/10.3390/ijms22158087] [PMID: 34360849]

[22]
Uzelac P, Stanczyk F, Nakajima S. Insulin, not human chorionic gonadotropin, is correlated with testosterone and free testosterone in gestational diabetes. Fertil Steril  2007; 87(S2): 1-13.
 [http://dx.doi.org/10.1016/j.fertnstert.2007.01.162]

[23]
Cobo-Vuilleumier N, Gauthier BR. Time for a paradigm shift in treating type 1 diabetes mellitus: coupling inflammation to islet regeneration. Metabolism  2020; 104: 154137.
 [http://dx.doi.org/10.1016/j.metabol.2020.154137] [PMID: 31904355]

[24]
Ohlsson C, Hammarstedt A, Vandenput L, et al. Increased adipose tissue aromatase activity improves insulin sensitivity and reduces adipose tissue inflammation in male mice. Am J Physiol Endocrinol Metab  2017; 313(4): E450-62.
 [http://dx.doi.org/10.1152/ajpendo.00093.2017] [PMID: 28655716]

[25]
Zahid H, Subbaramaiah K, Iyengar NM, et al. Leptin regulation of the p53-HIF1a/PKM2-aromatase axis in breast adipose stromal cells – a novel mechanism for the obesity-breast cancer link. Int J Obes  2018; 42(4): 711-20.
 [http://dx.doi.org/10.1038/ijo.2017.273] [PMID: 29104286]

[26]
Bahrami N, Jabeen S, Tahiri A, et al. Lack of cross-resistance between non-steroidal and steroidal aromatase inhibitors in breast cancer patients: The potential role of the adipokine leptin. Breast Cancer Res Treat  2021; 190(3): 435-49.
 [http://dx.doi.org/10.1007/s10549-021-06399-x] [PMID: 34554372]

[27]
Ibrahim MMH, Uddin MM, Bheemanapally K, Briski KP. Sex-dimorphic aromatase regulation of ventromedial hypothalamic nucleus glycogen content in euglycemic and insulin-induced hypoglycemic rats. Neurosci Lett  2020; 737: 135284.
 [http://dx.doi.org/10.1016/j.neulet.2020.135284] [PMID: 32853718]

[28]
Benod C, Vinogradova MV, Jouravel N, Kim GE, Fletterick RJ, Sablin EP. Nuclear receptor liver receptor homologue 1 (LRH-1) regulates pancreatic cancer cell growth and proliferation. Proc Natl Acad Sci  2011; 108(41): 16927-31.
 [http://dx.doi.org/10.1073/pnas.1112047108]

[29]
Cobo-Vuilleumier N, Lorenzo PI, Rodríguez NG, et al. LRH-1 agonism favours an immune-islet dialogue which protects against diabetes mellitus. Nat Commun  2018; 9(1): 1488.
 [http://dx.doi.org/10.1038/s41467-018-03943-0] [PMID: 29662071]

[30]
Nadolny C, Dong X. Liver receptor homolog-1 (LRH-1): A potential therapeutic target for cancer. Cancer Biol Ther  2015; 16(7): 997-1004.
 [http://dx.doi.org/10.1080/15384047.2015.1045693] [PMID: 25951367]

[31]
Kwon SS, Kwon JY, Park JW, Kim YH, Lim JB. HbA1C for diagnosis and prognosis of gestional daibetes mellitus. Diabetes Res Clin Pract  2015; 110(1): 38-43.

[32]
Rahnemaei FA, Pakzad R, Amirian A, Pakzad I, Abdi F. Effect of gestional daibetes mellitus on lipid profile. Open Med  2021; 17(1): 70-86.
 [http://dx.doi.org/10.1515/med-2021-0408]

[33]
Anjum F, Zaini R, Shami A, Rehaili A, Kufia R. Glycated hemoglobin and lipid profile association among pregnant women in Saudi Arabian population. Int J Women’s Health Reprod Sci  2019; 7(2): 216-22.
 [http://dx.doi.org/10.15296/ijwhr.2019.36]

Rights & Permissions Print Cite

Article Metrics

21

2

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/1573408019666221103145729	Print ISSN 1573-4080
Publisher Name Bentham Science Publisher	Online ISSN 1875-6662

Current Enzyme Inhibition

Aromatase Enzyme Activity and Liver Receptor Homolog-1 Levels in Gestational Diabetes Mellitus

Abstract

Graphical Abstract

Related Journals

Related Books

Related Articles